Clinical Trials Logo

Clinical Trial Summary

This study aims to investigate the concentration of various growth factors and cytokines in blood, and to examine the gut microbiota of low birth weight infants fed with formulas with or without Human Milk Oligosaccharide (HMO) supplement. Eligible low birth weight infants are allocated to two groups, Investigational formula (with HMO) or Control formula (without HMO). The subjects are taking the assigned formula when they need to be supplemented with formula. After the informed consent was obtained and eligibility was confirmed, the intervention period begins, and ends at the one-month-old medical check-up with the assessment of the various blood growth factors and cytokines, and the gut microbiota.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05203900
Study type Interventional
Source Meiji Co., Ltd.
Contact Mengjie Lin
Phone +81-042-632-5848
Email [email protected]
Status Recruiting
Phase N/A
Start date December 13, 2021
Completion date March 2024

See also
  Status Clinical Trial Phase
Completed NCT04313478 - The Relationship Between Segmental Trunk Control and Gross Motor Performance in Low Birth Weight Born Infant
Terminated NCT02168257 - Neotech RAM Cannula Versus Conventional Binasal Prong Continuous Positive Airway Pressure (CPAP) to Treat Respiratory Distress in Low Birth Weight Neonates N/A
Completed NCT03187938 - Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight